Stereotactic body radiotherapy for primary and metastatic liver tumors - the Mayo Clinic experience.

Kenneth W. Merrell(Mayo Clinic), Kenneth R. Olivier(Mayo Clinic), Christopher L. Hallemeier(Mayo Clinic in Arizona), Michael G. Haddock(Mayo Clinic in Arizona), Charles S. Mayo(Mayo Clinic), Brandon M. Barney(Mayo Clinic), J. Johnson(Mayo Clinic), K.E. Nelson(Mayo Clinic), Benjamin Mou(University of British Columbia)
PubMed
January 1, 2016
Cited by 7

Related Papers

Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445
Clinical Features and Outcome in North American Adults With Moyamoya Phenomenon
|Stroke|2006|337
Adjuvant Radiotherapy and Chemotherapy for Pancreatic Carcinoma: The Mayo Clinic Experience (1975-2005)
|Journal of Clinical Oncology|2008|270
Oesophageal cancer
|The Lancet|2024|265